Used in biomedical research to quantify levels of SREBP2 protein in rat samples, this ELISA kit enables studies on cholesterol metabolism and lipid regulation. It is particularly valuable in investigating molecular mechanisms related to hyperlipidemia, atherosclerosis, and metabolic syndrome. Researchers use it to assess how drugs, diets, or genetic modifications affect SREBP2 expression and activity in liver or other tissues. The kit supports high-throughput screening in preclinical studies focused on cardiovascular disease and cholesterol-lowering therapies.